SCHEMBL6264682

SCHEMBL6264682

O=C(O)C=CC=CC=Cc1ccc2c(c1)CCCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.52
CYP1A2 P05177 1/20 0.52
ALDH1A1 P00352 3/20 0.41
TRPV1 Q8NER1 1/20 0.40
KDM4E B2RXH2 3/20 0.40
ALOX5 P09917 2/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC3 O15379 1/20 0.40
CA12 O43570 1/20 0.40
AKR1B10 O60218 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
TTR P02766 1/20 0.40
MMP1 P03956 1/20 0.40
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615401 0.87 KDM4E (0.53) HSD17B10ALDH1A1TRPV1KDM4EALOX5
SCHEMBL7615406 0.87 KDM4E (0.53) HSD17B10ALDH1A1TRPV1KDM4EALOX5
SCHEMBL2728405 0.83 KDM4E (0.53) HSD17B10ALDH1A1TRPV1KDM4EALOX5
SCHEMBL2728401 0.83 KDM4E (0.53) HSD17B10ALDH1A1TRPV1KDM4EALOX5
Hydrochloric Acid SCHEMBL27910221 0.82 KDM4E (0.51) HSD17B10ALDH1A1TRPV1KDM4EALOX5
SCHEMBL30263749 0.80 KDM4E (0.56) HSD17B10ALDH1A1KDM4EALOX5MEN1
SCHEMBL30207038 0.80 KDM4E (0.56) HSD17B10ALDH1A1KDM4EALOX5MEN1
SCHEMBL13797243 0.80 KDM4E (0.56) HSD17B10ALDH1A1KDM4EALOX5MEN1
SCHEMBL20681307 0.80 KDM4E (0.56) HSD17B10ALDH1A1KDM4EALOX5MEN1
SCHEMBL30567327 0.80 KDM4E (0.56) HSD17B10ALDH1A1KDM4EALOX5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1587779-A1 5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL 2,6-DIFLUOROHEPTATRIENOIC ACID DERIVATIVES HAVING SERUM GLUCOSE REDUCING ACTIVITY Allergan, Inc. (US) 2005-10-26 EP disclosed
WO-2004065345-A1 5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL 2,6-DIFLUOROHEPTATRIENOIC ACID DERIVATIVES HAVING SERUM GLUCOSE REDUCING ACTIVITY ALLERGAN, INC. (US) 2004-08-05 WO disclosed
US-6759547-B1 REDUCES SERUM GLUCOSE AND SERUM TRIGLYCERIDE LEVELS IN DIABETIC MAMMALS WITHOUT THE UNDESIRABLE PROPERTIES OF REDUCING SERUM THYROXINE LEVELS AND TRANSIENTLY RAISING TRIGLYCERIDE LEVELS ALLERGAN, INC. 2004-07-06 US disclosed